Pages that link to "Q42216385"
Jump to navigation
Jump to search
The following pages link to The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin (Q42216385):
Displaying 22 items.
- Tigemonam, an oral monobactam (Q24674177) (← links)
- Enterobacter spp.: pathogens poised to flourish at the turn of the century (Q24683746) (← links)
- Cefepime (Q29040262) (← links)
- Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa (Q33693985) (← links)
- Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome (Q33750327) (← links)
- Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients (Q35137580) (← links)
- In vitro activity of cefepime against multidrug-resistant Gram-negative bacilli, viridans group streptococci and Streptococcus pneumoniae from a cross-Canada surveillance study (Q35649669) (← links)
- Comparative activity of cefepime with several antimicrobials against aerobic Gram-negative and Gram-positive organisms isolated from patients across Canada in 1993. (Q35893006) (← links)
- Randomized comparison of cefepime and ceftazidime for treatment of skin, surgical wound, and complicated urinary tract infections in hospitalized subjects (Q36757158) (← links)
- AmpC beta-lactamases (Q37366249) (← links)
- In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa (Q39832633) (← links)
- Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. (Q40389382) (← links)
- Cefepime clinical pharmacokinetics (Q40861609) (← links)
- Bacteriologic and clinical applications of a new extended-spectrum parenteral cephalosporin (Q41013988) (← links)
- Cefepime Versus Ceftazidime in the Treatment of Lower Respiratory Tract Infections (Q44533712) (← links)
- In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics (Q50177657) (← links)
- Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: in comparison with ceftazidime treatment. (Q50855483) (← links)
- A new therapeutic option for the treatment of pneumonia. (Q53756312) (← links)
- Susceptibility of new beta-lactams to the expanded-spectrum beta-lactamase CTX-1. (Q54365127) (← links)
- Susceptibility of bacterial isolates to beta-lactam antibiotics from U.S. clinical trials over a 5-year period (Q71181710) (← links)
- Comparative susceptibilities of Klebsiella species, Enterobacter species, and Pseudomonas aeruginosa to 11 antimicrobial agents in a tertiary-care university hospital (Q71181714) (← links)
- Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study Group (Q74468124) (← links)